Hotspot


Pharmaceutical Research | 2002

Macroflux Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization

James A. Matriano; Michel J. N. Cormier; Juanita Johnson; Wendy A. Young; Margaret Buttery; Kofi Nyam; Peter E. Daddona

AbstractPurpose. We evaluated the Macroflux® microprojection array patch technology as a novel system for intracutaneous delivery of protein antigens. Methods. Macroflux® microprojection array systems (330-μm microprojection length, 190 microprojections/cm2, 1- and 2-cm2 area) were coated with a model protein antigen, ovalbumin (OVA), to produce a dry-film coating. After system application, microprojection penetration depth, OVA delivery, and comparative immune responses were evaluated in a hairless guinea pig model. Results. Macroflux® microprojections penetrated into hairless guinea pig skin at an average depth of 100 μm with no projections deeper than 300 μm. Doses of 1 to 80 μg of OVA were delivered via 1- or 2-cm2 systems by varying the coating solution concentration and wearing time. Delivery rates were as high as 20 μg in 5 s. In a prime and boost dose immune response study, OVA-coated Macroflux® was most comparable to equivalent doses injected intradermally. Higher antibody titers were observed when OVA was administered with the microprojection array or intradermally at low doses (1 and 5 μg). Macroflux® administration at 1- and 5-μg doses gave immune responses up to 50-fold greater than that observed after the same subcutaneous or intramuscular dose. Dry coating an adjuvant, glucosaminyl muramyl dipeptide, with OVA on the Macroflux® resulted in augmented antibody responses. Conclusions. Macroflux® skin patch technology provides rapid and reproducible intracutaneous administration of dry-coated antigen. The depth of skin penetration targets skin immune cells; the quantity of antigen delivered can be controlled by formulation, patch wearing time, and system size. This novel needle-free patch technology may ultimately have broad applications for a wide variety of therapeutic vaccines to improve efficacy and convenience of use.


Archive | 2002

Microprojection array immunization patch and method

Michel J. N. Cormier; James A. Matriano; Peter E. Daddona; Juanita Johnson; Wendy A. Young; Richard L. Keenan; Joseph C. Trautman


Archive | 2001

Transdermal drug delivery devices having coated microprotrusions

Michel J. N. Cormier; Wendy A. Young; Kofi Nyam; Peter E. Daddona


Archive | 2002

Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition

Wendy A. Young; Michel J. N. Cormier


Archive | 2002

Microprojection array having a beneficial agent containing coating

Michel J. N. Cormier; Wendy A. Young; Juanita Johnson; Peter E. Daddona


Archive | 2003

Drug delivery device and method having coated microprojections incorporating vasoconstrictors

Michel J. N. Cormier; James A. Matriano; Wei Qi Lin; Wendy A. Young


Archive | 2001

Transdermal electrotransport device and method for manufacturing same

Lothar Kleiner; Wendy A. Young


Archive | 2005

Method of making a housing for drug delivery

Wendy A. Young; Lothar Kleiner


Archive | 2003

Method of coating transdermal drug delivery devices having coated microprotrusions

Michel J. N. Cormier; Wendy A. Young; Juanita Johnson; Peter E. Daddona; Mahoud Ameri


Archive | 2003

Coating process device Transdermal drug delivery having coated microportuberancias.

Mahoud Ameri; Michel J. N. Cormier; Peter E. Daddona; Juanita Johnson; Wendy A. Young

Researchain Logo
Decentralizing Knowledge